EUVIMEDEUVIMED entdecken
Open Access

Fertility preservation in men with hypogonadotropic hypogonadism secondary to germinoma: two cases of gonadotropin replacement therapy before induction of anticancer chemotherapy

Yasuhiro Kaku iD, Koji Chiba, Yosuke Yamashita, Shun Kawamura, Katsuya Sato, Takuto Hara, Keisuke Okada, Hideaki Miyake

International Cancer Conference Journal · 16.08.2024 · 13 (4) · 468-470

DOI: 10.1007/s13691-024-00711-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Cancer Conference Journal, online erschienen am 16.08.2024. Verfasst von Yasuhiro Kaku und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe-City, Hyogo Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypogonadotropic hypogonadism can be caused by brain tumors. For a malignancy such as a germ cell tumor, chemotherapy combined with radiation is administered. In patients who wish for children, the inability to undergo sperm cryopreservation before treatment because of impaired spermatogenesis and/or ejaculation dysfunction can be problematic. We herein present two cases involving a 26-year-old man and a 30-year-old man with hypogonadotropic hypogonadism due to an intracranial germinoma and both wished to have children. Gonadotropin replacement therapy prior to anticancer chemotherapy resulted in subsequent spontaneous pregnancy or assisted reproductive therapy. Subsequent treatment of the tumor resulted in no recurrence for 9 and 2 years, respectively. Close consultation with an oncologist is mandatory in such cases. Depending on the tumor prognosis, however, it may be possible to delay tumor treatment and prioritize fertility because there is a possibility of impaired spermatogenesis due to additional chemotherapy.

Schlagwörter

Stichwörter der Autor:innen

Brain TumorChemotherapyFertility PreservationHypogonadotropic HypogonadismInfertility

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe-City, Hyogo Japan.

ORCID-Profile: Yasuhiro Kaku

Zitieren

APA

Kaku, Y., Chiba, K., Yamashita, Y., Kawamura, S., Sato, K., Hara, T., Okada, K., & Miyake, H. (2024). Fertility preservation in men with hypogonadotropic hypogonadism secondary to germinoma: two cases of gonadotropin replacement therapy before induction of anticancer chemotherapy. International Cancer Conference Journal, 13(4), 468-470. https://doi.org/10.1007/s13691-024-00711-4

Vancouver

Kaku Y, Chiba K, Yamashita Y, Kawamura S, Sato K, Hara T, et al. Fertility preservation in men with hypogonadotropic hypogonadism secondary to germinoma: two cases of gonadotropin replacement therapy before induction of anticancer chemotherapy. International Cancer Conference Journal. 2024;13(4):468-470. doi:10.1007/s13691-024-00711-4

BibTeX
@article{Kaku2024,
  author = {Kaku, Yasuhiro and Chiba, Koji and Yamashita, Yosuke and Kawamura, Shun and Sato, Katsuya and Hara, Takuto and Okada, Keisuke and Miyake, Hideaki},
  title = {Fertility preservation in men with hypogonadotropic hypogonadism secondary to germinoma: two cases of gonadotropin replacement therapy before induction of anticancer chemotherapy},
  journal = {International Cancer Conference Journal},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {468--470},
  doi = {10.1007/s13691-024-00711-4}
}
Kostenlos starten →